CSMD1 and glioma: Both pSTAT3-Y705 and pP65-Ser536 showed enrichment in the nuclear and/or cytoplasmic fractions of Ctrl glioma cells treated with TNF, in contrast to the CSMD1-overexpressing glioma cells.